STOCK TITAN

OneMedNet Stock Price, News & Analysis

ONMD Nasdaq

Welcome to our dedicated page for OneMedNet news (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet stock.

OneMedNet Corporation (NASDAQ: ONMD) is frequently featured in news coverage for its role as a curator and provider of regulatory-grade, AI-ready Real-World Data through its iRWD™ platform. Company announcements highlight developments across its healthcare provider network, subscription offerings, technology partnerships, and relationships with life sciences, medical device, and healthcare AI organizations.

News about OneMedNet often focuses on expansion of its iRWD™ network, including increases in the number of provider sites, de-identified patient records, and clinical exams available for research and analytics. The company also reports on new subscription agreements and master service arrangements that provide customers with ongoing access to curated, multimodal datasets for AI model development, Real-World Evidence programs, and clinical research.

Another key theme in OneMedNet’s news flow is its collaboration with Palantir Technologies. Press releases describe how Palantir’s Artificial Intelligence Platform and Foundry environment are integrated with OneMedNet’s network to enable faster cohort discovery, AI-driven de-identification, and natural-language search across regulatory-grade Real-World Data. Coverage of industry events such as RSNA and ISPOR Europe frequently includes demonstrations of OneMedNet’s redesigned data exploration and cohort-building platform.

Investors and analysts following ONMD can also find updates on strategic partnerships, such as the company’s collaboration with Medcase in healthcare data annotation, and commentary on trends in demand for large-scale Real-World Data subscriptions. For a consolidated view of these developments, the ONMD news page on Stock Titan aggregates press releases, event-related updates, and other public communications so readers can review how OneMedNet’s strategy and operations are being presented over time.

Rhea-AI Summary

OneMedNet announced a significant expansion of its iRWD™ network and platform, boasting a more than five-fold increase.

The company has partnered with new entities, including a nationwide medical records custodian, increasing its network to 1,402 healthcare system and provider partner sites, 31 million patients, and 121.4 million clinical exams.

This growth represents a 472% increase in partner sites, a 170% rise in patients, and a 122% bump in clinical exams since the end of 2023.

CEO Aaron Green emphasized that this expansion aligns with OneMedNet's strategy to leverage real-world data for healthcare innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
200%
Tags
none
-
Rhea-AI Summary

OneMedNet , a leading curator of precision curated regulatory-grade Real World Data, will participate in the EF Hutton Annual Global Conference on May 15, 2024. The company's President & CEO and Founder & CMO will be presenting at the event, with management holding one-on-one investor meetings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.15%
Tags
none
-
Rhea-AI Summary

OneMedNet (Nasdaq: ONMD) has joined ClinEco Inc., a platform that enhances access and distribution for clinical research. This move validates OneMedNet's Real World Data platform within the clinical trial ecosystem. Aaron Green, President and CEO of OneMedNet, expressed excitement at becoming part of this community. ClinEco serves as a networking hub for clinical trial stakeholders, fostering collaboration and innovation in the life sciences sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.13%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.13%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
42.23%
Tags
partnership
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.18%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
168.21%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.54%
Tags
none

FAQ

What is the current stock price of OneMedNet (ONMD)?

The current stock price of OneMedNet (ONMD) is $1.02 as of May 8, 2026.

What is the market cap of OneMedNet (ONMD)?

The market cap of OneMedNet (ONMD) is approximately 53.7M.